IGHV unmutated status influences outcome more than IGHV1-69 gene usage per se in patients with chronic lymphocytic leukemia

Clinical Lymphoma and Myeloma

Volumn 9, Issue 5, 2009, Pages 390-393

  Orlandi, Ester ^a   Zibellini, Silvia ^a   Pascutto, Cristiana ^a   Picone, Cristina ^a   Giardini, Ilaria ^a   Pochintesta, Lara ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Binet stage; CD38; Gene rearrangement; HCDR3; ZAP70

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN 1-69 GENE; IMMUNOGLOBULIN HEAVY CHAIN GENE; MALE; PROGNOSIS; PROTEIN MOTIF; SOMATIC HYPERMUTATION;

EID: 70350686475     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.076     Document Type: Article

References (10)

1. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leucemia carry stereotyped receptors. Pathogenetic implications and clinical correlations. Blood 2007; 109:259-270.
2. Dagklis A, Fazi C, Sala C, et al. The immunoglobulin gene repertoire of low-count CLL like MBL is different from CLL: diagnostic implications for clinical monitoring. Blood 2009; 114:26-32.
3. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped pattern of somatic mutation in subsets of patients with chronic lymphocytic leukaemia: implications for the role of antigene selection in leukemogenesis. Blood 2008; 111:1524-1533.
4. Zibellini S, Arcaini L, Passamonti F, et al. Splenic marginal zone B-cell lymphoma: clinical clustering of immunoglobulin heavy chain repertoires. Blood 2008; 112: (Abstract 1775).
5. Walewska R, Majid A, Davis Z, et al. Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69. Leukemia 2007; 21:2537-2538.
6. Panovska-Stavridis I, Ivanovski M, Siljanovski N, et al. Chronic lymphocytic leukaemia patients with a V1-69 gene rearrangement do not have inferior survival with respect to patients that express other unmutated V(H) genes. Leuk Res 2007; 31:245-248.
7. Galligan L, Catherwood MA, Matthews C, et al. Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia. Leuk Lymphoma 2008; 49:763-768.
8. Thorsélius M, Kröber A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006; 107:2889-2894.
9. Kienle D, Benner A, Kröber A, et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood 2006; 107:2090-2093.
10. Guarini A, Chiaretti S, Tavolaro S, et al. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 2008; 112:782-792.